다나허 (DHR) 주가

다나허(DHR)는 NYSE에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $211.81 (-0.32%), 시가총액 $121.11B, PER (주가수익비율) 33.10, 52주 최저~최고 $161.91 ~ $242.05.

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and

핵심 지표

• 현재가: $211.81 (-0.32%)
• 시가총액: $121.11B
• PER (주가수익비율): 33.10
• 52주 최저~최고: $161.91 ~ $242.05
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NYSE

다나허의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

다나허 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.6154
• 평균 목표주가: $243.20
• 투자의견 분포: 매수 23 · 보유 3 · 매도 0

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.32
• PSR (주가매출비율): 6.04
• PEG: 1.85
• ROE (자기자본이익률): 0.07%
• ROA (총자산이익률): 0.04%
• 순이익률: 0.15%
• 영업이익률: 0.23%
• 배당수익률: 0.01%
• 배당성향: 0.21%

자주 묻는 질문